Innospec Inc. (NASDAQ:IOSP) Shares Sold by Leeward Investments LLC MA

Leeward Investments LLC MA reduced its holdings in shares of Innospec Inc. (NASDAQ:IOSP) by 0.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 69,408 shares of the specialty chemicals company’s stock after selling 536 shares during the quarter. Leeward Investments LLC MA owned approximately 0.28% of Innospec worth $8,554,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also made changes to their positions in IOSP. GAMMA Investing LLC acquired a new stake in shares of Innospec in the 4th quarter valued at about $44,000. Tocqueville Asset Management L.P. acquired a new stake in shares of Innospec in the 3rd quarter valued at about $203,000. Stonegate Investment Group LLC acquired a new stake in shares of Innospec in the 4th quarter valued at about $204,000. Evergreen Capital Management LLC boosted its position in shares of Innospec by 10.2% in the 3rd quarter. Evergreen Capital Management LLC now owns 2,210 shares of the specialty chemicals company’s stock valued at $226,000 after purchasing an additional 205 shares during the period. Finally, Oak Thistle LLC acquired a new stake in shares of Innospec in the 3rd quarter valued at about $229,000. 96.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Innospec news, CEO Patrick Williams sold 9,667 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $124.37, for a total transaction of $1,202,284.79. Following the completion of the sale, the chief executive officer now directly owns 174,334 shares of the company’s stock, valued at approximately $21,681,919.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CEO Patrick Williams sold 9,667 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $124.37, for a total transaction of $1,202,284.79. Following the completion of the transaction, the chief executive officer now directly owns 174,334 shares of the company’s stock, valued at approximately $21,681,919.58. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Philip John Boon sold 3,715 shares of the stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $122.07, for a total value of $453,490.05. Following the transaction, the vice president now directly owns 18,516 shares of the company’s stock, valued at $2,260,248.12. The disclosure for this sale can be found here. In the last ninety days, insiders sold 36,500 shares of company stock valued at $4,532,959. 1.52% of the stock is owned by company insiders.

Innospec Trading Up 0.8 %

Shares of NASDAQ IOSP traded up $1.02 during trading hours on Friday, reaching $121.12. The stock had a trading volume of 64,800 shares, compared to its average volume of 88,331. The firm has a market cap of $3.02 billion, a price-to-earnings ratio of 21.56 and a beta of 1.10. Innospec Inc. has a fifty-two week low of $91.74 and a fifty-two week high of $131.18. The firm has a 50-day moving average of $124.35 and a 200-day moving average of $115.77.

Innospec (NASDAQ:IOSP) last posted its quarterly earnings data on Tuesday, February 13th. The specialty chemicals company reported $1.84 earnings per share for the quarter, topping analysts’ consensus estimates of $1.59 by $0.25. Innospec had a return on equity of 13.69% and a net margin of 7.14%. The company had revenue of $494.70 million during the quarter, compared to analysts’ expectations of $479.47 million. During the same period last year, the firm earned $1.20 EPS. The firm’s revenue for the quarter was down 3.1% on a year-over-year basis. On average, equities analysts predict that Innospec Inc. will post 6.77 EPS for the current year.

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.